US Stocks
AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock

$13.83
-0.67 (-4.59%)

Volume:

1.527M ($21.13M)

Market Capitalization:

$4.35B

Amneal Pharmaceuticals Class A Price Chart

Amneal Pharmaceuticals Class A Price Chart 5:40 AM 7:00 AM 8:20 AM 9:40 AM 11:00 AM 12:20 PM 1:40 PM14.9514.7614.5714.3814.1813.9913.80

Amneal Pharmaceuticals Class A Volume Chart

Amneal Pharmaceuticals Class A Volume Chart 5:40 AM7:00 AM8:20 AM9:40 AM11:00 AM12:20 PM1:40 PM 54.10K46.37K38.64K30.91K23.18K15.46K7.73K

Amneal Pharmaceuticals Class A Market Segments

Regular Trading Hours

-0.40(-2.81%)
Open$14.23
Close$13.83
Low$13.80
Low Change-0.44 (-3.06%)
High$14.67
High Change+0.44 (+3.06%)
Range$0.87
Volume1.512M
Dollar Volume$20.92M

Premarket

-0.01(-0.07%)
Open$14.59
Close$14.58
Low$14.39
Low Change-0.20 (-1.37%)
High$14.95
High Change+0.36 (+2.47%)
Range$0.56
Volume14.663K
Dollar Volume$213.79K

After Hours Yesterday

+0.21(+1.45%)
Open$14.49
Close$14.70
Low$14.49
Low Change0.00 (0.00%)
High$14.85
High Change+0.36 (+2.48%)
Range$0.36
Volume38.386K
Dollar Volume$564.27K

Regular Trading Hours Yesterday

-0.09(-0.58%)
Open$14.58
Close$14.50
Low$14.31
Low Change-0.28 (-1.89%)
High$14.66
High Change+0.08 (+0.55%)
Range$0.36
Volume1.274M
Dollar Volume$18.47M

Premarket Yesterday

+0.06(+0.41%)
Open$14.69
Close$14.75
Low$14.69
Low Change0.00 (0.00%)
High$14.85
High Change+0.16 (+1.09%)
Range$0.16
Volume340
Dollar Volume$5.02K

Amneal Pharmaceuticals Class A Statistics

Average Volume (30 Days)3.15M
P/E Ratio (Current)729.00
EPS (Current)$0.02
Dividend Yield0.85%
Free Cash Flow$255.89M
Cash Ratio0.23
Current Ratio2.09
Quick Ratio1.38
Debt to Equity-23.51
Enterprise Value$6.96B
EV to EBITDA11.56
EV to Sales2.37
Price to Book-41.87
Price to Cash Flow13.98
Price to Free Cash Flow17.91
Price to Sales1.56
Return on Assets0.00%
Return on Equity-0.05%

Amneal Pharmaceuticals Class A Stock Splits

There has been 1 stock split for Amneal Pharmaceuticals Class A (AMRX). The reverse stock split occured on August 26, 2013 and reduced the outstanding shares at a ratio of 25:1.

DateTypeRatio
August 26, 2013Reverse25:1